Upgrade to SI Premium - Free Trial

Needham stays Buy on Lucid Diagnostics Inc (LUCD) as EsoGuard volumes surge

March 26, 2026 11:14 AM
Needham analyst Mike Matson reiterated a Buy rating and $3.00 price target on Lucid Diagnostics Inc (NASDAQ: LUCD)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments